Jose C. Tapia, Medical Oncologist at Velindre University NHS Trust, shared a post on X:
“Looking forward to ASCOGU25:
- Prostate: Combos with iPARP- and Lu- , EZH2.
- Urothelial: Updates, HER-2, FGFR3, and high-risk UTUC.
- Renal: Updates, UO3B, KIM-1, HIF-2 inh and MET inh.
- Testicular: RPLND advanced Seminoma.
- Penile: IO-chemo for advanced Ca.
